Thales advances €3.9bn Exail takeover as tender offer agreement is signed

Thales (Euronext Paris: HO) and Exail Technologies (Euronext Paris: EXA) confirmed on 31 July 2026 that the two groups had signed a formal tender offer agreement on 30 July, converting the binding heads of terms announced on 6 July into a contractual framework that governs how Thales will move from acquiring the Gorgé family’s 35.51% controlling stake to taking full ownership of the French maritime robotics and inertial navigation specialist. The terms are unchanged: €134.00 per Exail share, an implied enterprise value of €3.9 billion, and a 44% premium to Exail’s unaffected share price of €93.15 on 25 June, the day before Safran (Euronext Paris: SAF) publicly disclosed its own approach. The deal remains a two-stage transaction, with closing of the Gorgé block expected by the third quarter of 2027 and the mandatory tender offer for the balance targeted to close by the beginning of 2028 at the latest. The signing tightens execution discipline on both sides but does not eliminate the antitrust review, the long path to consolidation on the Thales balance sheet, or the arbitrage spread that has kept Exail shares trading meaningfully below the €134 bid. The central question for both shareholder bases now shifts from whether Thales will pay to whether the two groups can hold the strategic case together through a completion window that runs for eighteen months or more.

What does the July 30 tender offer agreement actually lock in for Thales and Exail shareholders?

The tender offer agreement is the contractual document that sets out the mechanics, representations, warranties, break fees, board obligations and information rights governing the transaction between signing and the mandatory tender offer filing with the Autorité des Marchés Financiers (AMF). Thales confirmed that the agreement mirrors the terms announced on 6 July, including the €134.00 price for both ordinary shares and the outstanding ODIRNANE convertible bonds, which will be tendered on economically equivalent terms.

The immediate procedural effect is that the tender offer cannot be filed until the acquisition of the 35.51% Gorgé family stake, comprising roughly 6,052,645 shares including securities under lending arrangements, has actually closed. Closing of that block is contingent on customary antitrust and regulatory approvals and is expected in the third quarter of 2027. Only once that block transfers will Thales file the mandatory tender offer with the AMF, after which the offer is expected to remain open through late 2027 and close by early 2028 at the latest. Exail’s Board of Directors unanimously and favourably welcomed the transaction on 6 July and continues to support it. An independent expert has been appointed to issue a fairness opinion on the price offered to minority shareholders, and an ad hoc board committee is monitoring that process, which is the standard French takeover-law framework for offers involving controlling shareholders.

For minority Exail shareholders, the signing means the €134 price is now embedded in an executed contract rather than a heads of terms. For Thales shareholders, the signing formally commits the group to deploy roughly €800 million to €820 million on the initial block, based on the Gorgé stake, followed by up to a further €2.1 billion to €2.3 billion for the balance of ordinary shares and convertible bonds if the tender is fully taken up, subject to final take-up rates and treasury shares held by Exail.

How does the €134 per share offer sit against Exail’s own operating momentum through the first half of 2026?

Exail’s own H1 2026 results, released alongside the Thales negotiation update in late July, reinforced the strategic thesis behind the offer. The group reported €479 million of revenue for 2025 and has guided for double-digit growth in 2026, with Q2 2026 delivering what management described as strong organic growth across both the Navigation and Maritime Robotics segment, which now generates roughly 76% of sales, and the Advanced Technologies segment covering photonics and quantum components. Exail is one of the leading global players in inertial navigation units used across naval, land and space applications, and it produces an integrated portfolio of underwater, surface and remotely operated maritime drones aimed at mine countermeasures, seabed mapping and, increasingly, anti-submarine warfare and intelligence, surveillance and reconnaissance missions.

At €134 per share, the offer values Exail’s equity at roughly €2.28 billion on the current share count of about 17.04 million, with the €3.9 billion enterprise value reflecting the group’s net debt, ODIRNANE bond position and other adjustments. That is broadly ten times reported 2025 revenue and around thirteen times consensus EBITDA of about €56 million, an implied multiple that sits well above the average for European industrials but is broadly consistent with recent European defence and dual-use technology transactions where scarcity value and sovereign sensitivity have supported elevated pricing.

The comparison against Safran’s rejected proposal is also material. Safran had offered €128.50 per share before ending exclusivity, and Thales’s €134 represents a 4.3% incremental premium on top. Given that Exail traded at an unaffected price of €93.15 on 25 June, the auction dynamic added roughly €43 per share, or about €730 million in equity value, above the pre-rumour level. Thales has framed that outcome as a disciplined outcome in line with its capital allocation framework, and management has confirmed no impact on the existing Thales dividend policy.

Why are Exail shares still trading below the €134 tender price after the agreement was signed?

Despite the binding contractual step on 30 July, Exail shares recently traded around €124, roughly 7.5% below the tender price. The arbitrage spread reflects three separable factors rather than any single fundamental doubt.

The first is time value. With the Gorgé block expected to close only in Q3 2027 and the mandatory tender offer running through late 2027 into early 2028, the cash for minority holders is between fifteen and eighteen months away. A high single-digit annualised discount is therefore consistent with normal cost of capital assumptions, particularly for a mid-cap European industrial with a large retail and institutional shareholder base.

The second is regulatory risk. The transaction is subject to antitrust and foreign investment review across multiple jurisdictions, and Thales has been explicit that the tender offer will only be filed with the AMF after those conditions are satisfied or waived. Underwater mine countermeasures, sonar systems and inertial navigation are areas where competition authorities in France, the wider European Union, the United Kingdom, and potentially the United States and Australia will need to assess overlaps against sovereign supply considerations. Thales already sits at the top of the global sonar market, including towed sonar systems used by many Western navies, and Exail is a leading supplier of unmanned mine countermeasures platforms; regulators will likely test whether the combination raises foreclosure risk for third-party integrators and shipbuilders.

The third factor is completion structure risk. The offer covers ordinary shares and the outstanding ODIRNANE bonds, and the transaction path depends on both the securities lending arrangement around a portion of Gorgé’s shares unwinding as planned and on Exail’s board and independent expert confirming the fairness of the price. None of these steps is contested at present, but each carries residual execution risk that markets typically price into the spread.

For Exail holders, the signing narrows but does not close that discount. For arbitrage-focused investors, the spread offers a defined pay-off pattern subject to the completion timeline and the antitrust track record of large European defence transactions.

What does Exail add to Thales’s underwater warfare, mine countermeasures and inertial navigation stack?

The industrial rationale is unusually well aligned with Thales’s existing capability map, which explains why the group was willing to top Safran to secure the asset. Thales is one of the world’s largest manufacturers of sonar systems, particularly towed sonar deployed by Western navies for anti-submarine warfare. Exail’s platforms complement rather than duplicate that portfolio. Its unmanned surface and underwater vehicles carry Exail-designed inertial navigation and sonar payloads that can be paired with Thales’s own submarine detection capabilities, creating a systems-level offering across the mine countermeasures and anti-submarine warfare mission set.

Two operational contexts have made that combination commercially urgent. The mine crisis in the Strait of Hormuz has renewed European and Middle Eastern demand for autonomous mine hunting solutions, which reduce the need to place crewed minesweepers into contested waters. Separately, Ukraine’s use of maritime surface drones against Russian naval assets in the Black Sea has demonstrated the operational value of low-cost autonomous platforms in denying sea control to conventionally stronger navies. Both examples have pulled forward navy procurement cycles for autonomous maritime systems across Europe, the United Kingdom, Australia and parts of Asia.

Exail also brings a scaled inertial navigation business used across naval, land and space applications, plus a photonics and quantum technologies portfolio that overlaps with Thales’s own advanced sensing and secure communications work. The group’s contract with NASA’s Jet Propulsion Laboratory to supply space-grade optical components for the Gravity Recovery and Climate Experiment Continuity mission and its 2025 acquisition of French laser maker Leukos illustrate the breadth of that adjacent technology stack, which extends the strategic value of the acquisition beyond the pure defence maritime robotics case.

Perhaps as important, Exail is ITAR-free, meaning it develops dual-use technologies without the United States export control constraints that would otherwise limit the ability to serve export customers in more than 80 countries. That characteristic dovetails with the European sovereignty push in defence technology and gives Thales a route into export markets that have prioritised non-United States supply for sensitive systems.

How does the run-rate synergy target of over €90 million by 2032 shape the near-term investment case?

Thales has quantified the value creation case around three headline metrics. Management expects the transaction to be accretive to revenue growth and to the adjusted EBIT margin profile from the year of consolidation. It targets run-rate revenue and cost synergies delivering an adjusted EBIT impact in excess of €90 million by 2032, with transaction-adjusted return on capital employed above the group’s weighted average cost of capital in year five post-closing. Management has framed the acquisition as consistent with its disciplined capital deployment framework and confirmed no impact on the current dividend policy.

Those numbers require careful reading. The €90 million run-rate synergy target is a 2032 outcome, five years after the Q3 2027 Gorgé block closing, which means the value contribution is heavily back-loaded relative to the deployment of cash. In the intervening years, Thales carries the acquisition financing and integration cost against Exail’s underlying operating performance, which in 2025 delivered roughly €56 million of EBITDA at an 11.8% margin.

For Thales shareholders, the near-term investment case therefore depends less on the €90 million synergy figure and more on Exail’s ability to sustain the double-digit revenue growth guided for 2026 and to convert its expanding order pipeline in unmanned maritime systems into cash-generative deliveries. Any softness in Exail’s own execution between now and the 2027 closing would compress the entry point without immediately unlocking synergies, which is the specific commercial risk Thales is underwriting.

The Thales share price reaction since the July 6 announcement has been muted rather than negative, with the stock trading in a €232 to €260 range through July before consolidating around €236 to €245, reflecting a market that broadly accepts the strategic logic while remaining alert to execution and timing risks. Analyst consensus price targets for Thales sit in a €288 to €292 range, well above the current share price, though these targets predate the tender offer signing and typically build in only limited near-term synergy contribution from the Exail acquisition.

What could reshape completion between the July 30 signing and the early 2028 tender offer close?

Several developments could still change the shape or timing of completion. Antitrust remedies are the most obvious source of adjustment; a European Commission or national regulator that demands divestitures in mine countermeasures, sonar or inertial navigation could reduce the strategic value Thales expects to capture, although the current market view is that remedies, if required, would be manageable given the fragmented state of the underwater warfare supply base outside the two companies.

Foreign investment review is a second area to watch. France has strengthened its foreign investment control framework in defence and dual-use technologies, and while Thales is a French national champion, the assessment will likely still cover the group’s ability to preserve sovereign supply commitments to allied navies. Adjacent reviews in the United Kingdom, Germany, Italy and Australia, all of which are current or prospective Exail customers, may extend the timeline but are unlikely to block the deal.

A third variable is Exail’s own operating trajectory. If the group materially outperforms its double-digit 2026 growth guidance and delivers stronger margin progression than management currently signals, minority shareholders and the independent expert reviewing fairness could revisit whether the €134 price still reflects long-term intrinsic value. In practice, once a binding tender offer agreement is signed and the AMF accepts the filing, opportunistic price revisions become procedurally difficult in the French framework, but investor pressure and independent expert commentary can still shape sentiment and completion take-up rates.

The remaining source of adjustment is the possibility of a competing bidder returning. Safran ended exclusive negotiations rather than being blocked, which means it or another European or United States defence prime could theoretically re-approach if Thales stumbles, though a topping bid would need to clear both the current binding contract and the same antitrust hurdles that face Thales itself.

Key Takeaways for Thales and Exail Technologies shareholders ahead of the tender offer filing

• Thales and Exail Technologies signed a formal tender offer agreement on 30 July 2026, converting the 6 July binding heads of terms into a contractual framework at unchanged terms of €134.00 per share and an implied €3.9 billion enterprise value.
• The Gorgé family 35.51% block is expected to close in the third quarter of 2027, with the mandatory tender offer for the balance filed afterwards and targeted to close by early 2028 at the latest.
• The offer represents a 44% premium to Exail’s unaffected share price of €93.15 on 25 June 2026 and beats Safran’s €128.50 per share proposal.
• Exail shares recently traded around €124, roughly 7.5% below the €134 offer, reflecting time value, antitrust review risk and completion structure risk rather than any current threat to board support.
• The strategic rationale combines Thales’s leadership in sonar and anti-submarine warfare with Exail’s leadership in unmanned mine countermeasures, inertial navigation and maritime drone platforms, in a defence market pulled forward by the Strait of Hormuz mine crisis and Black Sea maritime drone campaigns.
• Thales targets adjusted EBIT synergies in excess of €90 million by 2032 and transaction-adjusted return on capital employed above cost of capital by year five post-closing, with the value contribution back-loaded relative to the timing of cash outflow.
• Antitrust and foreign investment approvals across France, the European Union, the United Kingdom, the United States and Australia will govern the pace at which the transaction moves from signing to closing.
• Exail’s ability to sustain its double-digit 2026 revenue growth and improve margins between now and the 2027 closing is the specific near-term risk Thales shareholders are underwriting.
• The next measurable proof points are the AMF filing of the mandatory tender offer following Gorgé block closing, the independent expert’s fairness opinion, and Exail’s H2 2026 and 2026 full-year results.
• The €134 price is now embedded in an executed contract, but the arbitrage spread will only close as regulatory approvals progress and the completion timeline shortens.